Dr. Naomi Wolf Details Her Latest Jaw-Dropping Findings Regarding Pfizer's COVID Jab
Pfizer Injection Cripples People
One-time or recurring donations can be made through Ko-Fi:
Report 71: Musculoskeletal Adverse Events of Special Interest Afflicted 8.5% of Patients in Pfizerâs Post-Marketing Data Set, Including Four Children and One Infant. Women Affected at a Ratio of Almost 4:1 Over Men.
May 15, 2023 ⢠by Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) â Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt â wrote a review of musculoskeletal adverse events of special interest (AESIs) found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., â5.3.6â). This group of AESIs include diagnoses of arthralgia (joint pain), arthritis (joint inflammation), arthritis/bacterial, chronic fatigue syndrome, polyarthritis (inflammation of multiple joints), post-viral fatigue syndrome, and rheumatoid arthritis (an autoimmune and inflammatory disease).
It is important to note that the AESIs in the 5.3.6 document were reported to Pfizer for only a 90-day period starting on December 1, 2020, the date of the United Kingdomâs public rollout of Pfizerâs COVID-19 experimental mRNA âvaccineâ product.
Highlights of this report include:
3,600 cases of musculoskeletal AESIs were reported, which equates to 8.5% of the post-marketing data set of 42,086 cases/patients.
The 3,600 patients reported 3,640 adverse events. 1,614 (44%) were classified as serious.
The time from administration to adverse event ranged from less than 24 hours to 32 days. 50% of the events started within the first 24 hours after injection.
Of the cases where gender was reported, 2,760 individuals were female, and 711 were male â an almost 4:1 ratio of female to male.
Though mostly adults were affected with these AESIs, two adolescents, four children, and one infant also reported musculoskeletal AESIs during a time frame when Pfizerâs BNT162b2 mRNA COVID âvaccineâ was not approved for use in individuals under 16 years of age.
The most common adverse event was arthralgia/joint pain (3,525 or 97%), followed by 70 arthritis AESIs (2%), 26 rheumatoid arthritis AESIs (<1%) and 5 AESIs (<1%) polyarthritis.
Outcome for 3,662 of the adverse events were: 1,801 (49%) resolved or resolving, 959 (26%) not resolved, 49 (1%) resolved with sequelae, and 853 (23%) were unknown.
Pfizer concluded, âThis cumulative case review does not raise new safety issues. Surveillance will continue.â
Please read the full report below.
âThese monsters looked at whether the babies would get sick and die ... And they saw that they did, and they kept going.â
Related articles:Â
Dr. Mike Yeadon: âNo One Died of or Even With COVID, Because Itâs a Fictitious Disease.â
FDA: âVaccines Do NOT Require Demonstration of the Prevention of Infection or Transmissionâ
Effects on Mother and Child That Bear Out Mike Yeadonâs Warnings
Dr. Yeadon Warns: So-Called âCOVID Vaccinesâ Are Toxic by Design
GOD bless you Dr. Coleman - dear Creator please help us to help ourselves - deliver us from evil ...
GOOD NEWS HERE!
Natural immunity acquired fro having had C19 infection trumps the fake vax industry. Period!
https://americanfaith.com/covid-infection-provides-longer-lasting-immunity-and-more-durable-protection-against-future-infections-than-vaccination-journal-nature/